Missing a week of Mounjaro: what actually happens and what to do

Tirzepatide has a half-life of roughly five days, so some pharmacological activity remains for well over a week after a missed dose.
The general guidance is: if fewer than five days have passed since your missed dose, take it as soon as you remember; if more, skip it and resume on your usual day.
Nausea and other gastrointestinal side effects may temporarily increase when you restart after a gap, similar to the early weeks of treatment.
Repeated or prolonged gaps can reduce the effectiveness of the medicine — consistency supports the best results over time.

Missing a single weekly dose of Mounjaro (tirzepatide) happens. The honest answer is that one skipped injection is rarely a clinical crisis, but what you do next matters. Mounjaro stays active in the body for several days after each dose, so a brief gap usually means less disruption than people expect — though your prescriber, not this page, is the right person to guide your next step. Tirzepatide is a prescription-only medicine requiring ongoing clinical supervision, and any questions about your personal dosing schedule should go directly to a qualified prescriber.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How to think through a missed dose, what the evidence says, and when to call for help

How missing a week fits into Mounjaro's pharmacology

Tirzepatide works as a dual GIP and GLP-1 receptor agonist, and one of its practical features is a relatively long half-life, around five days. That means when a dose is missed, the medicine doesn't vanish from your system overnight. Some appetite-regulating effect carries forward into the days that follow.

This is why missing one dose rarely causes the dramatic return of hunger that people worry about. Your body hasn't reset. That said, by the time a full week has passed without a dose, blood levels will be meaningfully lower than they would be with consistent weekly dosing, and the appetite-modulating effect will have weakened noticeably.

Think of it in practical terms: the pen you keep in the fridge door is there to be used on the same day each week. If life gets in the way once, the treatment doesn't fail, but the routine is there for a reason. Consistency is what lets tirzepatide work at its best over the months of treatment, and if you're curious about the latest developments in how the treatment is evolving, our Mounjaro 2.0 page covers what's new. You can also read more about how tirzepatide works on our tirzepatide overview page.

What the standard guidance says about the five-day rule

The Mounjaro Patient Information Leaflet sets out clear advice for missed doses, and the NHS medicines information for tirzepatide reflects the same principle. If you realise you've missed your weekly injection and fewer than five days have passed since it was due, you can take the missed dose and then continue your usual weekly schedule from there. If five or more days have passed, the standard advice is to leave the missed dose entirely and resume your next injection on the day it was originally planned.

This preserves your weekly rhythm without doubling up, which could increase the risk of side effects. The five-day cut-off matters because beyond that point, administering the missed dose would effectively move your entire schedule, creating an irregular pattern that's harder for your body to adjust to. For the precise wording, the NHS tirzepatide medicines page carries patient-level guidance you can check directly.

If you've missed a dose and you're unsure which situation applies to you, contacting your prescribing service is always a reasonable step. Our team is reachable through the contact page if you're a nume patient.

Nausea, side effects, and restarting after a longer gap

One thing worth knowing before you restart is that a gap of a week or more can make your system behave a bit like it did in the first days of treatment. Gastrointestinal side effects (nausea being the most common, alongside digestive changes) tend to be most noticeable when tirzepatide levels are rising. After a break, levels have fallen and then climb again when the next dose arrives, which can briefly reproduce that early-adjustment feeling.

For most people this is mild and short-lived. Staying well hydrated and eating smaller, lower-fat meals around the time of restarting helps many patients. If side effects after a missed-and-resumed dose feel disproportionate, or if you're experiencing severe stomach pain that spreads towards the back, seek medical attention promptly, that pattern warrants urgent assessment regardless of whether a dose was missed. The MHRA highlighted acute pancreatitis as a recognised, though infrequent, side effect of GLP-1 medicines in a Drug Safety Update published in January 2026.

If you've missed more than two consecutive weeks, your prescriber may want to reassess before you continue at your current dose. There's a separate look at extended gaps on our page about missing two weeks of Mounjaro.

When to involve your prescriber rather than self-manage

A single missed dose is generally something you can navigate using the five-day guidance above. But there are situations where speaking to your prescriber is the right call, not just a precaution.

If you've missed a dose because you've been unwell (particularly with significant vomiting or diarrhoea) your prescriber needs to know, because dehydration alongside a GLP-1 medicine carries its own risks. If you're unsure whether to restart at your current dose or step back to a lower one after a longer break, that decision belongs with a clinician. And if you've missed a week because you simply ran out of supply before your next order arrived, it's worth reviewing how you plan refills so the gap doesn't repeat.

On that last point, questions about cost or supply interruptions come up often. Our Mounjaro cost page covers what's involved in private treatment pricing. If you're not yet on treatment and this page came up while you were considering starting, the treatment page explains the consultation process from the beginning.

For a deeper look at the practicalities of missed doses, the pages on missing a week of Mounjaro and what to do if you've already missed one cover specific scenarios in more detail. Our prescribers at nume review every patient's case individually, if something feels off after restarting, reaching out is always the right instinct.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions